中国的基因疗法。健择的疗效：难以转化。（注：这里“Gendicine”可能是特定的药品名“健择”，不过不太明确其具体所指，如果不是特定药品名，可能翻译会更不准确，你可根据实际情况判断） - Suppr

Suppr

超能文献

Chinese gene therapy. Gendicine's efficacy: hard to translate.

作者信息

Xin Hao

出版信息

Science. 2006 Nov 24;314(5803):1233. doi: 10.1126/science.314.5803.1233.

DOI:10.1126/science.314.5803.1233

PMID:17124301

Abstract

摘要

相似文献

Chinese gene therapy. Gendicine's efficacy: hard to translate.

Science. 2006 Nov 24;314(5803):1233. doi: 10.1126/science.314.5803.1233.

Chinese gene therapy. Splicing out the West?

Science. 2006 Nov 24;314(5803):1232-5. doi: 10.1126/science.314.5803.1232.

Cancer gene therapy--clinical perspective 1995.

Cancer Gene Ther. 1996 Jan-Feb;3(1):3.

[Gene therapy in The Netherlands].

Ned Tijdschr Geneeskd. 2007 Sep 8;151(36):1975-80.

Clinical trial design for adenoviral gene therapy products.

Drug News Perspect. 2009 Apr;22(3):140-5. doi: 10.1358/dnp.2009.22.3.1354090.

Cancer gene therapy clinical trials.

Cancer Gene Ther. 1995 Mar;2(1):5-6.

Gene therapy of cancer in the clinic: good news in sight from Asia?

Curr Opin Mol Ther. 2007 Oct;9(5):477-82.

[Prospects of biological study of carcinoma in China from the clinical trials of gene therapy with p53].

Zhonghua Yi Xue Za Zhi. 2003 Dec 10;83(23):2017.

Web alert. Gene therapy in cancer treatment.

Curr Opin Mol Ther. 2000 Aug;2(4):359.

Gene therapy finds welcoming environment in China.

Nat Med. 2006 Mar;12(3):263-4. doi: 10.1038/nm0306-263.

引用本文的文献

Development of Cas13a-based therapy for cancer treatment.

Mol Biol Rep. 2024 Jan 9;51(1):94. doi: 10.1007/s11033-023-09129-2.

Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages.

Cancer Cell Int. 2023 Jan 5;23(1):1. doi: 10.1186/s12935-022-02846-x.

Not gene therapy, but genetic surgery-the right strategy to attack cancer.

Mol Gen Microbiol Virol. 2009;24(3):93-113. doi: 10.3103/S089141680903001X. Epub 2009 Oct 8.

The potential for tumor suppressor gene therapy in head and neck cancer.

Discov Med. 2016 Jan;21(113):41-7.

The business case for cell and gene therapies.

Nat Biotechnol. 2014 Dec;32(12):1192-3. doi: 10.1038/nbt.3084.

The DNA binding domain of p53 is sufficient to trigger a potent apoptotic response at the mitochondria.

Mol Pharm. 2013 Oct 7;10(10):3592-602. doi: 10.1021/mp400380s. Epub 2013 Sep 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验